Cargando…
Exosomal LGALS9 in the cerebrospinal fluid of glioblastoma patients suppressed dendritic cell antigen presentation and cytotoxic T-cell immunity
Glioblastoma multiforme (GBM) is highly invasive, with a high recurrence rate and limited treatment options, and is the deadliest glioma. Exosomes (Exos) have attracted much attention in the diagnosis and treatment of GBM and are expected to address the severe limitations of biopsy conditions. Exos...
Autores principales: | Wang, Ming, Cai, Yang, Peng, Yong, Xu, Bo, Hui, Wentao, Jiang, Yugang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582167/ https://www.ncbi.nlm.nih.gov/pubmed/33093453 http://dx.doi.org/10.1038/s41419-020-03042-3 |
Ejemplares similares
-
Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases
por: Costa, Júlia, et al.
Publicado: (2020) -
Single‐cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastoma
por: Finotto, Lise, et al.
Publicado: (2023) -
A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9)
por: Lv, Yan, et al.
Publicado: (2022) -
COT-3 Exosomal microRNA expression signature in blood and cerebrospinal fluid of glioblastoma patients
por: Yamashita, Daisuke, et al.
Publicado: (2021) -
Galectin-9 gene (LGALS9) polymorphisms are associated with rheumatoid arthritis in Brazilian patients
por: Vilar, Kamila de Melo, et al.
Publicado: (2019)